Pharmaceuticals, Biotechnology and Life Sciences
– Special Meeting of Stockholders to be Held Virtually on September 5, 2025 – – Live Stockholder Fireside Chat to…
REDWOOD CITY, Calif., July 24, 2025 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing…
MTX-001 recognized for its clinical and commercial potential for treating chronic non-healing venous leg ulcers (VLUs)RESEARCH TRIANGLE PARK, N.C., July…
Cabometyx® is the first and only systemic therapy to be approved in the European Union for previously treated unresectable or…
H1 2025 revenue First-half activity H1 revenue of €387.8 million, down 5.4% at CER1 and like-for-like2 largely due to the…
This Herbal Brain Booster supports short-term focus and long-term brain health, offering calm, clean mental energy without jitters or burnoutBrooklyn,…
COPENHAGEN, Denmark, July 24, 2025 – Bavarian Nordic A/S (OMX: BAVA) has become aware of market rumours regarding a potential…
Carlsbad, CA, July 23, 2025 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical-stage biopharmaceutical company focused…
Abivax Announces Launch of Public Offering PARIS, France, July 23, 2025 – 10:15 p.m. (CEST) – Abivax SA (Euronext Paris:…
FREMONT, Calif., July 23, 2025 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it…